Putney aims to compete in generic pet drug market with new launch
PORTLAND, Maine — Putney has launched a generic version of a veterinary skin infection drug, the company said.
Putney announced the launch of cefpodoxime proxetil, a generic version of Pfizer’s Simplicef, used to treat certain skin infections in dogs. Putney said its product was the only generic version of Simplicef approved by the Food and Drug Administration.
According to IMS Health, generics now account for more than 80% of prescription drugs dispensed to humans, but an analysis of the FDA’s Center for Veterinary Medicine approvals indicated that only 7% of medicines for dogs and cats have a generic version.
"Pet owners are looking for more affordable, equivalent medications to treat their pet family members, just like the FDA approved generic drugs that they are comfortable using when doctors prescribe medication for their human family," Putney president and CEO Jean Hoffman said.
Galderma drug for common skin condition becomes available
FORT WORTH, Texas — A topical medication made by Galderma Labs for treating melasma of the face is now available in pharmacies, Galderma said.
Tri-Luma (fluocinolone acetonide 0.01%, hydroquinone 4%), tretinoin 0.05%) is described as the only Food and Drug Administration-approved triple combination topical product for the short-term treatment of moderate to severe melasma. The chronic skin condition affects more than 7 million people in the United States.
Melasma causes brown to gray-brown patches of skin due to the body producing too much melanin, usually appearing on the face, but also sometimes the forearms and neck. The condition is sometimes referred to as "the mask of pregnancy" because it is so common during pregnancy, but there are many factors associated with it, including birth control pills, hormone therapy, cosmetics, anti-seizure drugs and sun exposure. It is more common among people of Latin, Asian, Indian, Middle Eastern, Mediterranean and North African descent.
NCPA to hold 45th annual Legislative Conference in May
ALEXANDRIA, Va. — The National Community Pharmacists Association on Tuesday announced it will hold its 45th annual Legislative Conference May 7 to 8 in Washington, D.C.
“This is a pivotal year for independent community pharmacy, with issues such as cuts to Medicare reimbursement rates for diabetes testing supplies, mandatory mail order programs and changes to compounding regulations on the table,” stated Douglas Hoey, NCPA CEO. “With the creation and expansion of state healthcare exchanges also taking shape this year, the role of the pharmacist in the delivery of healthcare services is more important than ever. Our Legislative Conference will give members of Congress and others a chance to hear directly from the people on the front lines of providing patient care in their local communities."
The conference will feature panels and briefings with congressional and federal agency staff, a rally on Capitol Hill and personal visits with members of Congress.
The event will coincide with Community Pharmacy Advocacy Week May 6-10. That week, community pharmacists will meet with their elected officials and other decisionmakers in Washington and at home, as well as state policymakers, to discuss bipartisan pro-patient, pro-pharmacist policies to improve health outcomes and reduce costs.
This year, NCPA is debuting a new, shorter conference schedule to give NCPA members more flexibility while still maximizing their time and advocacy efforts during their visit to Washington. The registration fee has also been reduced to ease the cost of attending, the association noted.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.